Local failure after radical radiotherapy of non-small cell lung cancer in relation to the planning FDG-PET/CT.

about

Local failure after radical radiotherapy of non-small cell lung cancer in relation to the planning FDG-PET/CT.

Item

http://www.wikidata.org/entity/Q48181398

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

Local failure after radical ra ...... on to the planning FDG-PET/CT.

@en

Local failure after radical ra ...... on to the planning FDG-PET/CT.

@nl

type

Item

label

Local failure after radical ra ...... on to the planning FDG-PET/CT.

@en

Local failure after radical ra ...... on to the planning FDG-PET/CT.

@nl

prefLabel

Local failure after radical ra ...... on to the planning FDG-PET/CT.

@en

Local failure after radical ra ...... on to the planning FDG-PET/CT.

@nl

P1476

Local failure after radical ra ...... on to the planning FDG-PET/CT.

@en

P2093

D Sloth Moeller

http://www.w3.org/2001/XMLSchema#string

H H Schmidt

http://www.w3.org/2001/XMLSchema#string

M Kandi

http://www.w3.org/2001/XMLSchema#string

P2860

The use of fused PET/CT images for patient selection and radical radiotherapy target volume definition in patients with non-small cell lung cancer: results of a prospective study with mature survival data.

Postradiation changes in tissues: evaluation by imaging studies with emphasis on fluorodeoxyglucose-PET/computed tomography and correlation with histopathologic findings.

Standard-dose versus high-dose conformal radiotherapy with concurrent and consolidation carboplatin plus paclitaxel with or without cetuximab for patients with stage IIIA or IIIB non-small-cell lung cancer (RTOG 0617): a randomised, two-by-two facto

Defining local-regional control and its importance in locally advanced non-small cell lung carcinoma

Using fluorodeoxyglucose positron emission tomography to assess tumor volume during radiotherapy for non-small-cell lung cancer and its potential impact on adaptive dose escalation and normal tissue sparing.

Identification of residual metabolic-active areas within individual NSCLC tumours using a pre-radiotherapy (18)Fluorodeoxyglucose-PET-CT scan.

Meta-analysis of concomitant versus sequential radiochemotherapy in locally advanced non-small-cell lung cancer.

Integrating stereotactic body radiation therapy in stage II/III non-small cell lung cancer: is local control important?

International association for the study of lung cancer (IASLC) lymph node map: radiologic review with CT illustration.

Areas of high 18F-FDG uptake on preradiotherapy PET/CT identify preferential sites of local relapse after chemoradiotherapy for non-small cell lung cancer.

P304

813-819

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1080/0284186X.2017.1409436

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Lone Hoffmann

Azza A Khalil

Marianne Marquard Knap

P577

2017-12-05T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29205088

http://www.w3.org/2001/XMLSchema#string

P921

radiation therapy